Renal-dose dopamine: will the message now get through?
- PMID: 11191531
- DOI: 10.1016/S0140-6736(00)03484-X
Renal-dose dopamine: will the message now get through?
Erratum in
- Lancet 2001 Mar 17;357(9259):890
Comment in
-
Dopamine dose and renal damage.Lancet. 2001 May 26;357(9269):1707-8. doi: 10.1016/S0140-6736(00)04838-8. Lancet. 2001. PMID: 11428365 No abstract available.
Comment on
-
Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.Lancet. 2000 Dec 23-30;356(9248):2139-43. doi: 10.1016/s0140-6736(00)03495-4. Lancet. 2000. PMID: 11191541 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical